<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/229410-method-for-preparing-pyrimidin-4-one-compounds by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 10:06:02 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 229410:METHOD FOR PREPARING PYRIMIDIN-4-ONE COMPOUNDS</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">METHOD FOR PREPARING PYRIMIDIN-4-ONE COMPOUNDS</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention relates to provide a novel process for producing a pyrimidin-4-one compound in high yield from easily available and lowly dangerous starting-material compounds under relatively simple, mild reaction conditions. The process for producing a pyrimidin-4-one compound comprises reacting an arylaminocarboxylic acid compound with an organic acid compound in the presence of a nitrogenous compound.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td> <br><br>
METHOD FOR PREPARING PYRIMIDIN-4-0NE COMPOUNDS<br>
[Field of Invention]<br>
The present invention relates to a method for preparing pyrimidin-4-one compounds.<br>
[Background of Invention]<br>
The pyrimidin-4-one compounds such as quinazolin-4-one compounds, pyrazolopyrimidin-5-one compounds, and thienopyrimidinone compounds are useful compounds as starting compounds or intermediate compounds for preparing pharmaceutically active chemical compounds and agricultural chemical compounds.<br>
Chem. Pharm. Bull,, 46 1926(1998) describes a method for preparing a pyrimidin-4-one by reacting anthranil-ic acid with formamide.<br>
EP 1029853A describes a method for preparing 6-iodo-quinazolin-4-one by reacting 5-iodoanthranilic acid with formamidine acetate in ethanol for 20 hours.<br>
J. Org. Chem., 18., 138(1953) describes a method for preparing quinazolin-4-one by reacting methyl anthrani-late with formamide in the presence of ammonium formate.<br>
J. Med. Chem., 41, 4021(1998) describes that 3-ben-zyl-2-butyl-3H-pyrido [3,2-d] pyrimidin-4-one hydrochloride is obtained with a yield of 8% by reacting 3-amino-2-pyridinecarboxylic acid with pentanoic acid anhydride at 140°C and further reacting the reaction product with benzylamine at 200°C.<br>
WO 01/98284 describes that pyrazolopyrimidin-7-one is prepared with a yield of 7% by 4-amino-l-methyl-n-propyl-lH-pyrazol-5-carboxylate with a benzamidine compound in xylene.<br>
Angew. Chem. Int. Ed. Engl., 2, 136(1968) describes a method of reacting an aminothiophenecarBoxylic acid<br><br>
conpound with a variety of nitrogen atom-containing compounds (e.g., formamide, nitriles, imino esters).<br>
The  above-mentioned various methods for preparing pyrimidin-4-one conpounds have problems in the complicated reaction involved, yields, and the use of dangerous starting conpounds.<br>
[Disclosure of Invention]<br>
[Object of Invention]<br>
The present invention ha.s  a main object to provide a novel method for preparing a pyrimidin-4-one compound. Particularly, the invention has an object to provide a novel method for preparing a pyrimidin-4-one compound with a high yield under simple and moderate reaction conditions from easily available starting conpounds leaving low dangerous properties.<br>
[Summary of Invention]<br>
The present invention resides in a method for preparing a pyrimidin-4-one compound having the formula (5) :■<br><br>
in which Ar represents an aromatic hydrocarbyl or heterocyclic ring optionally having a substituent, Ra represents hydrogen or a hydrocarbyl group, and Rb represents an atom or a group which does not participate in the below-mentioned reaction, provided that Rb is other than hydrogen where Ra is hydrogen;<br>
which comprises reacting an aminoarylcarboxylic acid compound having the formula (1) :<br><br><br>
in which Ar has the above-mentioned meaning, and R1 represents hydrogen or a hydrocarbyl group; with an organic acid compound having the formula (4) :<br><br>
in which R3 represents a hydrocarbyl group, and R6 has the above-mentioned meaning;<br>
in the presence of a nitrogen atom-containing compound having the formula (2) or (3):<br><br>
in which R2 represents hydrogen or a hydrocarbyl group, and Ra has the above-mentioned meaning.<br>
Preferred embodiments of the invention are described below.<br>
(1)	The reaction is performed in an organic solvent .<br>
(2)	The organic solvent is a polar solvent.<br>
(3)	The polar solvent is a lower alcohol having 1 to 6 carbon atoms.<br>
(4)	The nitrogen atom-containing corrpound is an amine compoud or ammonium acetate.<br>
(5)	The reaction is performed at a temperature in the range of 40 to 200°C.<br>
(6)Arisa5-or 6-membered aromatic hydrocarbyl ring optionally having a substituent.<br>
(7)' Ar is a 5- or 6-membered aromatic heterocyclic<br><br>
ring optionally having a substituent,<br>
(8)	The pyrimidin-4-one compound has the formula<br>
(7): <br>
in which each of Ra and Rb has the meaning defined as above, each of R4, R5, R6 and R7 independently represents an atom or a group which does not participate in the reaction, provided that R4, R5, R6 and R7 can form a ring in optional combinations, and each of X1, X2, X3 and X4 independently represents a carbon atom or a nitrogen atom, provided that, where any of X1, X2, X3 and X4 are nitrogen atoms, the nitrogen atoms do not have the atom or group thereon,<br>
and the aminoarylcarboxylic acid compound is an aminocarboxylic acid compound having the formula (6) :<br><br>
in which each of X1 X2 X3 X4 R4 R5 R6 and R7 has the meaning defined as above, and R8 represents an atom or a group which does not participate in the reaction.<br>
(9)	The pyrimidin-4-one compound is a quinazolin-4-<br>
one compound having the formula (9) :<br><br><br>
in which each of Ra and Rb has the meaning defined as above, each of R4, R5, R6 and R7 independently represents an atom or a group which does not participate in the reaction, provided that R4, R5, R6 and R7 can form a ring in optional combinations,<br>
and the aminoarylcarboxylic acid compound is an anthranilic acid having the formula (8) :<br><br>
in which each of R4, R5, R6, and R7 has the meaning defined as above, and R8 represents an atom or a group which does not participate in the reaction.<br>
(10) The pyrimidin-4-one compound is a pyxazolo-pyrimidin-7-one compound having the formula (11) :<br><br>
in which each of Ra and Rb has the meanina defined as<br><br>
above, each of R9 and R10 independently represents an atom or a group which does not participate in the reaction, provided that R9 and R10 can form a ring in combination,<br>
and the aminoarylcarboxylic acid compound is an aminopyrazolcarboxylic acid having the formula (10) :<br><br>
in which each of R9 and R10 has the meaning defined as above, and R8 represents an atom or a group which does not participate in the reaction.<br>
(11) The pyrimidin-4-one compound is a thieno-pyrimidine compound having the formula (13) :<br><br>
in which each,of Ra and Rb has the meaning defined as above, each of R4, R5, and R6 independently represents an atom or a group which does not participate in the reaction, provided that R4, R5, and R6 can form a ring in optional combinations, and at least one of X5, X6 and X7 represents a sulfur atom, and other is carbon atom, provided that, where any of X5, X6 and X7  are sulfur atoms, the sulfur atoms do not have the atom or group thereon, and the .aminoarylcarboxylic acid compound is an<br>
aminothiophenecarboxylic acid compound having the forrnula (12).<br><br><br>
in which each of X4 X5, X6, R4 R5, and R6 has the meaning defined as above, and R8 represents an atom or a group which does not participate in the reaction.<br>
[Effects of Invention]<br>
The method of the invention enables to prepare pyrimidin-4-one compounds with high yields londer simple and moderate reaction conditions from easily available staorting compounds having low dangerous properties.<br>
[Preferred Embodiments of Invention]<br>
Ar, Ra, R, R1 R2, R3 R4   R5 R6 R7   R8 R9 and R10 of the aforementioned formulas are described below in more detail.<br>
Ar is an aromatic hydrocarbyl (or hydrocartbon) ring or an aromatic heterocyclic ring. These rings can have a substituent.  Preferred are 5- or 6-membered aromatic hydrocarbyl rings and 5- or 6-membered aromatic heterocyclic rings which can have a substituent.<br>
Ra is a hydrogen atom or a hydrocarbyl group. Examples of the hydrocarbyl group are alkcyl groups having 1 to 12 carlbon atoms such as methyl, ethyl, propyl, Ibutyl, pentyl, hexyl, heptyl, octyl, nonyl, and decyl; cycloallcyl groups having 3 to 12 carlDon atoms such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl; aralkyl groups having 7 to 22 carbon atoms such as benzyl/ phenethyl, and phenylpropyl; and aryl groups such as phenyl, p-tolyl, naphthyl, and anthryl.<br><br>
Rb is an atom or a group which does not participate the reaction involved in the method of the invention. Examples include hydrogen atom, alkyl groups, cycloalkyl groups, aralkyl groups, aryl groups, halogen atoms, hy-droxyl group, alkoxy groups, alkylthio groups, nitro group, cyano group, carbonyl group, amino groups, and carboxyl group.  These groups can further have a substi-tuent which does not participate in the reaction involved.  Examples of the substituents are those described hereinbefore.  Examples of the halogen atoms include fluorine, chlorine, bromine, and iodine.  The alkylthio groups can be methylthio, ethylthio, or propylthio.<br>
R1 is a hydrogen atom or a hydrocarbyl (hydrocarbon) group.  Examples of the hydrocarbyl groups are those described for Ra.<br>
R2 is a hydrogen atom or a hydrocarbyl (hydrocarbon) group.  Examples of the hydrocarbyl groups are those described for Ra.<br>
R3 is a hydrocarbyl (hydrocarbon) group.  Examples of the hydrocarbyl groups are those described for Ra.<br>
R4, R5 R6 R7   R8 R9 and R10 are the same as or different from each other, can have a substituent, and are groups which do not participate in the reaction. Exarrples of these groups include hydrogen atom, alkyl groups, cycloalkyl groups, aralkyl groups, aryl groups, halogen atoms, hydroxyl group, alkoxy groups, alkylthio groups, nitro group, cyano group, carbonyl group, amino groups (except for R4) , and carboxyl group (except for<br>
The alkyl groups can be methyl, ethyl, propyl, butyl , pentyl, hexyl, heptyl, octyl, nonyl, or decyl. These groups can be in any isomer forms.<br>
The cycloalkyl groups can be cyclopropyl, cyclo-butyl, cyclopentyl, cyclohexyl, cycloheptyl, or cyclo-octyl.<br>
The aralkyl groups can be benzyl, phenethyl, or<br><br>
phenylpropyl.  These groups can be any isomer forms.<br>
The aryl groups can be phenyl, p-tolyl, naphthyl, or anthryl.  These groups can be in any isomer forms.<br>
The halogen atoms can be fluorine, chlorine, bromine, or iodine.<br>
The alkoxy groups can be methoxy, ethoxy, or prop-oxy. These groups can be in any isomer forms.<br>
The alkylthio groups can be methylthio, ethylthio, or propylthio-  These groups can be in any isomer forms.<br>
The alkyl groups, cycloalkyl groups, aralkyl groups, aryl groups, alkoxy groups, alkylthio groups and amino groups can have a substituent.  The substituent can be a substituent connected via a carbon atom, a substituent connected via an oxygen atom, a substituent connected via a nitrogen atom, a substituent connected via a sulfur atom, or a halogen atom.<br>
Exatrples of the substituents connected via a carbon atom include alkyl groups such as methyl, ethyl, propyl, butyl, pentyl, and hexyl, cycloalkyl groups such as cyclopropyl, eyclobutyl, eyclopentyl, and eyclohexyl, alkenyl groups such as vinyl, alkyl, propenyl, cyclo-propenyl, cyclobutenyl, and cyclopentenyl, heterocyclic groups such as pyrrolidyl, pyrrolyl, furyl, and thienyl, aryl groups such as phenyl, tolyl, xylyl, biphenylyl, naphthyl, anthoryl, and phenanthzyl, acyl groups (which can be acetallized) such as formyl, acetyl, propionyl, acryloyl, pivaloyl, cyclohexylcarbonyl, benzoyl, naphthoyl, and toluoyl, carboxyl groups, alkoxycarbonyl groups such as methoxycarbonyl and ethoxycarbonyl, aryloxycarbonyl groups such as phenoxycarbonyl, haloge-nated alkyl groups such as trifluoromethyl, and cyano group. These groups can be in any isomer forms.<br>
Examples of the substituents connected via an oxygen atom include hydroxyl group, alkoxy groups such as methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, hept-yloxy, benzyloxy, piperidyloxy, and pyranyloxy, and aryl-<br><br>
OXy groups such as phenox, tolyloxy, and naphthyloxy. These gxoups can be in any isomer forms.<br>
Examples of the sxibstituents connected via a nitrogen atom include primary amino groups such as methyl-amino, ethylamino, butylamino, eye lohexylamino,  phenyl -amino, and naphthylamino, secondary amino groups such as dimethylamino,   diethylamino, dibutylamino, methylethyl -amino, methybutylamino, and diphenylamino, heterocyclic amino groups such as morpholino, thiomorpholino, piperi-dino, piperazinyl, pyrazolidinyl, pyrrolidine, and indolyl.  These groups can be in any isomer forms.<br>
Examples of the substituents connected via a sulfur atom include mercapto group, thioalkoxy groups such as thiomethoxy, thioethoxy, and thiopropoxy, and thioaryloxy groups such as thiophenoxy, thiotolyloxy and thionaphth-yloxy.  These groups can be in any isomer forms.<br>
Examples of the halogen atoms include fluorine, chlorine, bromine, and iodine. <br>
The reaction involved in the preparation method of the invention is further described below.<br>
The nitrogen atom-containing compound of the aforementioned formula (2) or (3) cam be employed preferably in an amount of 1 to 100 moles, more preferably in an amount of 3 to 40 moles, per one mole of the aminoaryl-carboxylic acid.  The nitrogen atom-containing compound can be in any of gas, liquid,, and solid.  Otherwise, the compound can be employed in a solution in an organic solvent such as a polar solvent (e.g., alcohol) .<br>
The organic acid compound of the formula (4) can be employed preferably in an amount of 1.0 to 15 moles, more preferably in an amount of 1.1 to 5.0 moles, per one mole of the aminoarylcarboxylic acid.<br>
The reaction, involved in the method of the invention can be carried out in the presence or absence of a solvent. There are no specific limitations with respect to the solvents, under the condition that the solvent does<br><br>
not give adverse effect to the reaction.  Examples of the solvents include alcohols such as methanol, ethanol, iso-propyl alcohol, n-butyl alcohol, t-butyl alcohol, and n-pentanol, amides such as N,N-dimethyIformamide and N-methylpyrrolidone, ureas such as N,N'-dimethylimidazoli-dinone, sulfoxides such as dimethyl sulfoxide, aromatic hydrocarbons such as benzene, toluene, xylene, and mesitylene, halogenated hydrocarbons such as methylene chloride, chloroform, and dichloroethane, nitriles such as acetonitrile and propionitrile, and ethers such as diethyl ether, tetrahydrofuran, and dioxane.  Preferred are alcohols, amides, and nitriles.  More preferred are methanol, ethanol, N, N'-dimethylimidazolidinone, and acetonitrile.  The solvents can be used singly or in combination.<br>
The solvent can be employed preferably in an amount of 0 to 50 g, more preferably 0 to 20 g, most preferably 0 to 5 g, per one mole of the aminoarylcarboxylic acid. The amount may vary depending on the condition of the liquid reaction mixture and/or easiness for stirring.<br>
The reaction involved in the method of the invention can be carried out by mixing and stirring the nitrogen atom-containing compound, aminoarylcarboxylic acid compound, organic acid compound, and solvent under inert gas atmosphere.  The temperature for the reaction is preferably in the range of 40 to 200°C, more preferably 50 to 150°0.  There is no limitation on pressure for the reaction.<br>
The final product, i.e., the pyrimidin-4-one compound, can be isolated and purified after completion of the reaction by known methods such as extraction, filtration, concentration distillation, recrystallization, and/or column chromatography.<br>
The invention is further described by the following examples.<br><br>
[Example 1] Synthesis of 6-iodo-2-methylquina2olin-4-one<br>
In a pressure resistant, 10 mL-volume stainless steel vessel, 1.00 g (3.8 mmol) of 5-iodoanthranilic acid, 2.47 g (15.2 mmol) of ethyl orthoacetate, and 5.0 mL (38 mmol) of 15 wt.% ammonia-methanol solution were heated at 125°C for 8 hours for performing a reaction. After the reaction was complete, the reaction mixture was cooled to room temperature and concentrated.  To the concentrated reaction mixture was added 20 mL of water, to precipitate a crystalline product.  The crystalline product was collected by filtration, to give 0.94 g (yield after isolation: 86%) of 6-iodo-2-methylquinazol-in-4-one as a white crystalline product.<br>
The 6-iodo-2-methylquinazolin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 5 (ppm) ) : 2.33 (3H, s) , 7.36 (1H, d, J=8.5 Hz), 8.04 (1H, dd, J=8.6, 2.1 Hz),- 8.35 (1H, d, J=2.0 Hz), 12.23 (1H, brs)<br>
CI-MS (m/e): 287 (M+1)<br>
[Exarrple 2] Synthesis of 6-iodo-3-methylquinazolin-4-one<br>
The procedures of Example 1 were repeated except that 2.47 g (15.2 mmol) of ethyl orthoacetate and 5.0 mL (38 mmol) of 15 wt.% ammonia-methanol solution were replaced with 1.61 g (15.2 mmol) of methyl orthoformate and 5.0 mL (28 mmol) of 20 wt.% methylamine-methanol solu--tion, respectively.  There was obtained 0.98 g (yield after isolation: 90%) of 6-iodo-3-methylquinazolin-4-one as a brownish gray crystalline product.<br>
The 6-iodo-3-methylquinazolin-4-one had the following properties:<br>
1H-NMR (DMSO-d1, 6 (ppm) ) : 3.94 (3H, s) , 7.46 (1H, d, J=8.4 Hz), 8.09 (IH, dd, J-8.4, 1.8 Hz), 8.40-8.42 (2H, m)<br>
CI-MS (m/e): 287 (M+1)<br><br>
[Example 3] Synthesis of 6-iodo-2,3-dimethylquinazolin-4-one<br>
The procedures of Example 1 were repeated except that 5-0 mL (38 mmol) of 15 wt.% ammonia-methanol solution were replaced with 5.0 mL (28 mmol) of 20 wt.% me-thylamine-methanol solution.  There was obtained 0.83 g (yield after isolation: 73%) of 6-iodo-2,3-dimethyl-quinazolin-4-one as a white crystalline product.<br>
The 6-iodo-2,3-dimethylquinazolin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 6 (ppm) ) : 2.56 (3H, s) , 3.31 (3H, s) , 3.52 (3H, s), 7.36 (IH, d, J=8.4 Hz), 8.04 (1H, dd, J=8.5, 1.8 Hz), 8.36 (1H, d, J=2.1 Hz)<br>
CI-MS (m/e): 301 (M+1)<br>
[Example 4] Synthesis of 6-iodo-3-phenylquinazolin-4-one<br>
In a pressure resistant, 20 mL-volume stainless steel vessel, 1.00 g (3.8 mmol) of 5-iodoanthranilic acid, 1.13 g (15.2 mmol) of ethyl orthoformnate, 0.71 g (7.6 mmol) of aniline, and 10 mL of n-pentanol were heated at 125°C for 8 hours for performing a reaction.  After the reaction was complete, the reaction mixture was cooled to room temperature and concentrated.  To the concentrated reaction mixture was added 20 mL of water, to precipitate a crystalline product.  The crystalline product was collected by filtration, to give. 0.87 g (yield after isolation: 66%) of 6-iodo-3-phenylquinazol-in-4-one as a white crystalline product.<br>
The 6-iodo-3-phenylquinazolin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 5 (ppm) ) : 7.51-7.58 (6H, m) , 8.17 (IH, dd, J=8.7, 2.4 Hz), 8.39 (1H, s) , 8.46 (1H, d, J=2.1 Hz)<br>
CI-MS (m/e): 349 (M+1)<br>
[Example 5]   Synthesis of 6-iodo-3-benzylquinazolin-4-one<br><br>
In a pressure resistant, 20 mL-volume stainless steel vessel, 1.00 g (3.8 mmol) of 5-iodoanthranilic acid, 1.13 g (15.2 mmol) of ethyl orthoformate, 0.81 g (7.6 mmol) of benzylamine, and 10 mL of n-pentanol were heated at 125°C for 8 hours for performing a reaction. After the reaction was complete, the reaction mixture was cooled to room temperature and concentrated.  To the concentrated reaction mixture was added 4 mL of 1 mol/L hydrochloric acid, to precipitate a crystalline product. The crystalline product was collected by filtration, to give 1.36 g (yield after isolation: 99%) of 6-iodo-3-benzylquinazolin-4-one as a white crystalline product.<br>
The 6-iodo-3-ben2ylquinazolin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 6 (ppm) ) : 3.32 (2H, s) , 7.32-7.36 (5H, m), 7.49 (IH, d, J=8.7 Hz), 8.11 (1H, d, J=2.1 Hz), 8.42 (IH, d, J=1.8 Hz), 8.61 (1H, s)<br>
CI-MS (m/e): 363 (M+1)<br>
[Example 6] Synthesis of 3H-pyrido [2,3-d]pyrimidin-4-one.<br>
In a pressure resistant, 10 mL-volume stainless steel vessel, 1.00 g (7.2 mmol) of 2-aminonicotinic acid, 3.07 g (28.8 mmol) of methyl orthoformate, and 5.0 mL (38 mmol) of 15 wt.% ammonia-methanol solution were heated at 105°C for 8 hours for performing a reaction.  After the reaction was complete, the reaction mixture was cooled to room terrperature and concentrated under reduced pressure, to give 1.06 g (yield after isolation: 100%) of 3H-pyrido [2,3-d]pyrimidin-4-one as a black solid product.<br>
The 3H-pyrido[2,3-d]pyrimidin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 6 (ppm) ) : 3.36 (1H, brs) , 7.46 (1H, dd, J=8.0, 4.5 Hz), 8.31 (1H, s), 8.45 (1H, dd, J=7.8, 2.1 Hz), 8.87 (IH, dd, J=4.8, 2.1 Hz)<br>
CI-MS (m/e): 148 (M+1)<br><br>
[Reference Example 1] Synthesis of 4-amino-l-methyl-3-n-propyl-2H-pyrazole-5-carboxylic acid<br>
In a 200 mL-volume glass reaction vessel equipped with a stirrer, a thermometer and a reflux condenser, 10.0 g (46.9 mmol) of l-methyl-4-nitro-3-n-propyl-2H-pyrazol-5-carboxylic acid, 2 g of 5 wt.% Pd/C (water content: 50%) , and 100 mL of ethanol were stirred at 50°C for 5 hours in a hydrogen atmosphere, for perfo3rming a reaction.  After the reaction was complete, the reaction mixture was cooled to room temperature, filtered, and concentrated under reduced pressure, to give 8.0 g (yield after isolation: 80%) of 4-amino-l-methyl-3-n-propyl-2H-pyrazol-5-carboxylic acid as a red solid product.<br>
The 4-amino-l-methyl-3-n-propyl-2H-pyrazol-5-carbox-ylic acid had the following properties:<br>
^H-NMR (DMSO-d^, 6 (ppm) ) : 0.98 (3H, t, J-7.6 Hz), 1,63-1.70 (2H, m) , 2.51 (2H, t, J=7.2 Hz), 4.01 (3H, s), 6.96 (3H, brs)<br>
CI-MS (m/e): 184 (M+1)<br>
[Exanple 7] Synthesis of l-methyl-3-n-propyl-l, 6-dihydro-pyrazolo [4,3 -d] pyrimidin-7-one<br>
In a pressure resistant, 10 mL-volume stainless steel vessel, 0.85 g (4.64 mmol) of 4-amino-1-methyl-3-n-propyl-2H-pyrazole-5-carboxylic acid prepared in Reference Exarrple 1, 1.74 g (16.4 mmol) of methyl orthoform-ate, and 5.0 mL (38 mmol) of 15 wt.% ammonia-methanol solution were heated at 120°C for 8 hours for performing a reaction. After the reaction was complete, the reaction mixture was cooled to room temperature and concentrated under reduced pressure, to give 0.48 g (yield after isolation: 54%) of l-methyl-3-n-propyl-l, 6-dihydropyrazolo-[4,3-d]pyrimidin-7-one as a black solid product.<br>
The l-methyl-3-n-propyl-l, 6-dihydropyrazolo [4,3-d] -pyrimidin-7-one had the following properties:<br>
^H-NMR (DMSO-d6, 6 (ppm) ) : 0.91 (3H, t, J=7.5 Hz),<br><br>
1.68-1.75 (2H, m) , 2.74 (2H, t, J=7.2 Hz), 4.12 (3H, s) , 7.80 (1H, s)<br>
CI-MS (m/e): 193 (M+1)<br>
[Exarrple 8] Synthesis of 3H-thieno [3,2-d]pyrimidin-4-one<br>
In a pressure resistant, 10 mL-volume stainless steel vessel, 1.00 g (6.36 mmol) of methyl 3-aminothio-phene-2-carboxylate, 2.02 g (19.1 mmol) of methyl ortho-formate, and 5.0 mL (38 mmol) of 15 wt.% ammonia-methanol solution were heated at 130°C for 7 hours for performing a reaction. After the reaction was complete, the reaction mixture was cooled to room temperature and concentrated under reduced pressure.  To the concentrated reaction mixture were successively added 50 mL of ethyl acetate and 50 mL of water.  The aqueous portion was separated from the organic portion.  The aqueous portion was concentrated to dryness under reduced pressure, to give 0.84 g (yield after isolation: 87%) of 3H-thieno [3,2-d]-pyrimidin-4-one as a black solid product.<br>
The 3H-thieno [3,2-d]pyrimidin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 6 (ppm) ) : 7.29 (1H, d, J=5.1 Hz), 7.99 (IH, d, J=5.5 Hz), 8.12 (IH, s)<br>
CI-MS (m/e): 153 (M+1)<br>
[Exanple 9] Synthesis of 6-iodo-2-methylquinazolin-4-one<br>
In a pressure resistant, 10 mL-volume stainless steel vessel, 1.22 g (15.8 mmol) of ammonium acetate, 1.00 g (3.8 mmol) of 5-iodoanthranilic acid, 2.54 g (15.7 mmol) of ethyl orthoacetate, and 5.0 mL of methanol were heated at 130°C for 16 hours for performing a reaction. After the reaction was complete, the reaction mixture was cooled to room temperature and concentrated.  To the concentrated reaction mixture was added 30 mL of water, to precipitate a crystalline product.  The crystalline product was collected by filtration, to give 0.348 g<br><br>
(yield after isolation: 32%) of 6-iodo-2-methylquinazol-in-4-one as a white crystalline product.<br>
The 6-iodo-2-methylquinazolin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 6 (ppm) ) : 2.33 (3H, s) , 7.36 (1H, d, J=8.5 Hz), 8.04 (IH, dd, J=:8.6, 2.1 Hz), 8.35 (IH, d, J=2.0 Hz), 12.23 (1H, brs)<br>
CI-MS (m/e): 287 (M+1)<br>
[Example 10] Synthesis of 3H-thieno [3, 2-d] pyrimidin-4-one<br>
In a pressure resistant, 10 mL-volume stainless steel vessel, 2.04 g (25 mmol) of ammonium acetate, 1,00 g (6.36 mmol) of methyl 3 -aminothiophene-2 -carboxylate, 2.76 g (26 mmol) of methyl orthoformate, and 5.0 mL of methanol were heated at 60-70°C for 6 hours for performing a reaction.  After the reaction was complete, the reaction mixture was cooled to room temperature and analyzed (according to absolute quantitative analysis) by high performance liquid chromatography.  There was produced 0.91 g (reaction yield: 94%) of 3H-thieno[3,2-d]pyrimid-in-4-one.  The reaction mixture was then concentrated under reduced pressure.  To the concentrated reaction mixture was added 40 mL of water, to precipitate a solid product, to give 0.26 g (yield after isolation: 27%) of 3H-thieno [3,2-d]pyrimidin-4-one as a brown solid product.<br>
-The 3H-thieno [3,2-d]pyrimidin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 6 (ppm) ) : 7.40 (1H, d, J=5.4 Hz), 8.15 (1H, s), 8.18 (IH, d, J=5.4 Hz), 12.48 (1H, brs) CI-MS (m/e): 153 (M+1)<br>
[Example 11.] Synthesis of 2-methyl-3H-pyrido [2, 3-d]-pyrimidin-4 -one<br>
In a pressure resistant, 10 mL-volume stainless steel vessel, 1.63 g (21.1 mmol) of ammonium acetate, 0.70 g (5.07 mmol) of 2-aminonicotinic acid, 3.39 g (20.9<br><br>
mmol) of methyl orthoacetate, and 3.2 mL of methanol were heated at 130°C for 16 hours for performing a reaction. After the reaction was complete, the reaction mixture was cooled to room temperature and concentrated under reduced pressure.  The concentrated reaction mixture was washed with 30 mL of chloroform, and purified by silica gel chromatography (column: Wakogel C-200, developing solvent.: ethyl acetate and methanol, in sequence) to give 0.40 g (yield after isolation: 49%) of 2-methyl-3H-pyrido [2,3-d]pyrimidin-4-one as a pale yellow solid product.<br>
The 2-methyl-3H-pyrido [2, 3-d]pyrimidin-4-one hadthe following properties:<br>
-H-NMR (DMSO-d6, 6 (ppm) ) : 2.33 (3H, s) , 7.36 (1H, d, J=8.5 Hz), 8.04 (IH, dd, J-8.5, 2.2 Hz), 8.33 (IH, d, ■ J=2.0 Hz), 12.33 (IH, brs)<br>
CI-MS (m/e): 162 (M+1)<br>
[Example 12] Synthesis of 1,5-dihydropyrazolo [3,4-d]-pyrimidin-4-one<br>
In a pressure resistant, 10 mL-volume stainless steel vessel, 1.99 g (25.8 mmol) of ammonium acetate, 1.00 g (7.09 mmol) of ethyl 5-amino-lH-pyrazole-4-carbox-ylate, 2.74 g (25.8 mmol) of methyl orthoformate, and 5.0 mL of methanol were heated at 130°C for 8 hours for performing a reaction. After the reaction was complete, the reaction mixture was cooled to room temperature and concentrated under reduced pressure, to give 0.85 g (yield after isolation: 88%) of 1, 5-dihydropyrazolo [3, 4-d]-pyrimidin-4-one as a black solid product.<br>
The 1, 5-dihydropyrazolo [3,4-d]-pyrimidin-4-one had the following properties:<br>
1H-NMR (DMSO-d6, 6 (ppm)) : 3.35 (1H, brs), 8.01 (1H, s), 8.13 (1H, s), 12.83 (1H, brs)<br>
CI-MS (m/e): 137 (M+1)<br><br><br><br><br><br>
WHAT IS CLAIMED IS:<br>
1.  A method for preparing a pyrimidin-4-one compound having the formula (5) :<br><br>
in which Ar represents an aromatic hydrocarbyl or heterocyclic ring optionally having a substituent, Ra represents hydrogen or a hydrocarbyl group, and Rb represents an atom or a group which does not participate in the below-mentioned reaction, provided that Rb is other than hydrogen where Ra is hydrogen;<br>
which comprises reacting an aminoarylcarboxylic acid compound having the fomula (1) :<br><br>
in which Ar has the above-mentioned meaning, and R1 represents hydrogen or a hydrocarbyl group; with an organic acid compound having the formula (4) :<br><br>
in which R3 represents a hydrocarbyl group, and Rb has the above-mentioned meaning;<br>
in the presence of a nitrogen atom-containing compound having the formula (2) or (3) :<br><br>
RaNHs	(2)<br>
R2CO2NH3R      (3)<br>
in which R2 represents hydrogen or a hydrocarbyl group, and Ra has the above-mentioned meaning.<br>
2.	The method of claim 1, in which the reaction is performed in an organic solvent.<br>
3.	The method of claim 2,   in which the organic solvent is a polar solvent.<br>
4.	The method of claim 3, in which the polar solvent is a lower alcohol having 1 to 6 carbon atoms.<br>
5.	The method of claim 1, in which the nitrogen atom-containing compound is an amine compound or ammonium acetate.<br>
6.	The method of claim 1, in which the reaction is performed at a temperature in the range of 40 to 200OC.<br>
7.	The method of claim 1, in which Ar is a 5- or 6-membered aromatic hydrocarbyl ring optionally having a siibstituent,<br>
8.	The method of claim 1, in which Ar is a 5- or 6-membered aromatic heterocyclic ring optionally having a substituent.<br>
9.	The method of claim 1, in which the pyrimidin-4-one compound has the formula (7) ;<br><br><br>
in which each of Ra and Ra has the meaning defined as above, each of R4, R5, R6 and R7 independently represents an atom or a group which does not participate in the reaction, provided that R4, R5, R6 and R7, can form a ring in optional combinations, and each of X1, X2, X3 and X4 independently represents a carbon atom or a nitrogen atom, provided that, where any of X1, X2, X3 and X4, are nitrogen atoms, the nitrogen atoms do not have the atom or group thereon,<br>
and the aminoarylcarboxylic acid compound is an aminocarboxylic acid compound having the formula (6) :<br><br>
in.which each of X1, X2 X3 X4 R4, R5, R6, and R7 has the meaning defined as above, and R8 represents an atom or a group which does not participate in the reaction.<br>
 10. The method of claim 1, in which the pyrimidin-4-one compound is a quinazolin-4-one compound having the formula (9) :<br><br><br>
in which each of Ra and Rb has the meaning defined as above, each of R4, R5, R6 and R7 independently represents an atom or a group which does not participate in the reaction, provided that R4, R5, R6 and R7 can form a ring in optional combinations,<br>
and the aminoarylcarboxylic acid compound is an anthranilic acid having the forrnula (8) :<br><br>
in which each of R4, R5, R6, and R7 has the meaning defined as above, and R8 represents an atom or a group which does not participate in the reaction.<br>
11.  The method of claim 1, in which the pyrimidin-4-one corrpound is a pyrazolopyrimidin-7-one compound having the forrnula (11) :<br><br><br>
in which each of Ra and Rb has the meaning defined as above, each of R9 and R10 independently represents an atom or a group which does not participate in the reaction, provided that R9 and R10 can form a ring in combination,<br>
and the aminoarylcarboxylic acid compound is an aminopyrazolcarboxylic acid having the formula (10) :<br><br>
in which each of R9 and R10 has the meaning defined as above, and R8 represents an atom or a group which does not participate in the reaction.<br>
12. The method of claim 1, in which the pyrimidin-4-one compound is a thienopyrimidine compound having the formula (13):    <br><br>
in which each of Ra and Rb has the meaning defined as above, each of R4, R5, and R6 independently represents an atom or a group which does not participate in the reac- tion, provided that R4, R5, and R6 can form a ring in optional combinations, and at least one of X5, X6 and X7 represents a sulfur atom, and other is carbon atom, pro-vided that, where any of X5, X6 and X7 are sulfur atoms., the sulfur atoms do not have the atom or group thereon, and the aminoarylcarboxylic acid compound is an<br><br>
aminothiophenecarboxylic acid compound having the formula (12):<br><br>
in which each of X4, X5, X6, R4 R5, and R6 has the meaning defined as above, and R8 represents an atom or a group which does not participate in the reaction.<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDE3MC1jaGVucC0yMDA2IGFic3RyYWN0LWR1cGxpY2F0ZS5wZGY=" target="_blank" style="word-wrap:break-word;">0170-chenp-2006 abstract-duplicate.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDE3MC1jaGVucC0yMDA2IGNsYWltcy1kdXBsaWNhdGUucGRm" target="_blank" style="word-wrap:break-word;">0170-chenp-2006 claims-duplicate.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDE3MC1jaGVucC0yMDA2IGRlc2NyaXB0aW9uIChjb21wbGV0ZSktZHVwbGljYXRlLnBkZg==" target="_blank" style="word-wrap:break-word;">0170-chenp-2006 description (complete)-duplicate.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtYWJzdHJhY3QucGRm" target="_blank" style="word-wrap:break-word;">170-chenp-2006-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtY2xhaW1zLnBkZg==" target="_blank" style="word-wrap:break-word;">170-chenp-2006-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtY29ycmVzcG9uZG5lY2Utb3RoZXJzLnBkZg==" target="_blank" style="word-wrap:break-word;">170-chenp-2006-correspondnece-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtY29ycmVzcG9uZG5lY2UtcG8ucGRm" target="_blank" style="word-wrap:break-word;">170-chenp-2006-correspondnece-po.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtZGVzY3JpcHRpb24oY29tcGxldGUpLnBkZg==" target="_blank" style="word-wrap:break-word;">170-chenp-2006-description(complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtZm9ybSAxLnBkZg==" target="_blank" style="word-wrap:break-word;">170-chenp-2006-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtZm9ybSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">170-chenp-2006-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtZm9ybSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">170-chenp-2006-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MTcwLWNoZW5wLTIwMDYtcGN0LnBkZg==" target="_blank" style="word-wrap:break-word;">170-chenp-2006-pct.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="229409-an-inhibitor.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="229411-engine-decompression-system.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>229410</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>170/CHENP/2006</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>12/2009</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>20-Mar-2009</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>17-Feb-2009</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>13-Jan-2006</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>UBE INDUSTRIES, LTD</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>1978-96, O-Aza Kogushi, Ube-shi, Yamaguchi, 755-8633,</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>NISHINO, Shigeyoshi</td>
											<td>c/o Ube Laboratories, Ube Industries, Ltd., 1978-5, O-Aza Kogushi, Ube-shi, Yamaguchi, 755-8633,</td>
										</tr>
										<tr>
											<td>2</td>
											<td>HIROTSU, Kenji</td>
											<td>c/o Ube Laboratories, Ube Industries, Ltd., 1978-5, O-Aza Kogushi, Ube-shi, Yamaguchi, 755-8633,</td>
										</tr>
										<tr>
											<td>3</td>
											<td>SHIMA, Hidetaka</td>
											<td>c/o Ube Laboratories, Ube Industries, Ltd., 1978-5, O-Aza Kogushi, Ube-shi, Yamaguchi, 755-8633,</td>
										</tr>
										<tr>
											<td>4</td>
											<td>SUZUKI, Shinobu</td>
											<td>c/o Ube Laboratories, Ube Industries, Ltd., 1978-5, O-Aza Kogushi, Ube-shi, Yamaguchi, 755-8633,</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07D 239/90</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/JP04/08640</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2004-06-18</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>2003-172873</td>
									<td>2003-06-18</td>
								    <td>Japan</td>
								</tr>
								<tr>
									<td>2</td>
									<td>2003-197904</td>
									<td>2003-07-16</td>
								    <td>Japan</td>
								</tr>
								<tr>
									<td>3</td>
									<td>2003-179077</td>
									<td>2003-06-24</td>
								    <td>Japan</td>
								</tr>
								<tr>
									<td>4</td>
									<td>2003-291426</td>
									<td>2003-08-11</td>
								    <td>Japan</td>
								</tr>
								<tr>
									<td>5</td>
									<td>2003-342772</td>
									<td>2003-10-01</td>
								    <td>Japan</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/229410-method-for-preparing-pyrimidin-4-one-compounds by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 10:06:03 GMT -->
</html>
